首页>Ophthalmic plastic and reconstructive surgery>Reply Re: Comparison of preferences between onabotulinumtoxina (botox) and incobotulinumtoxina (xeomin) in the treatment of benign essential blepharospasm"
Reply Re: Comparison of preferences between onabotulinumtoxina (botox) and incobotulinumtoxina (xeomin) in the treatment of benign essential blepharospasm"
作者单位：University of Turku, Faculty of Medicine, Turku, Finland, Department of Neurology, Turku University[1]Department of Ophthalmology, Saint Louis University, St. Louis, MO 63104, United States[2]
换一批
